Stockreport

Arch Therapeutics Receives Recommendation That CE Mark Be Granted [Seeking Alpha]

Arch Therapeutics, Inc.  (ARTH) 
NASDAQ:AMEX Investor Relations: ir.archtherapeutics.com
PDF Arch Therapeutics Receives Recommendation That CE Mark Be Granted Summary Arch Therapeutics' AC5 recommended for European approval. There was no press release on the rec [Read more]